Dennis M Fenton insider trades

Open-market stock purchases and sales by Dennis M Fenton, Unknown at First Tracks Biotherapeutics, Inc, from SEC Form 4 filings since May 11, 2010.

Recent trades

DateStockTradeValue
Jun 15, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
May 12, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
May 12, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
May 12, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
May 12, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Apr 20, 2026TRAX First Tracks Biotherapeutics, IncBought (not open market)—
Jan 6, 2026ANAB Anaptysbio, IncBought (not open market)—
Jan 6, 2026ANAB Anaptysbio, IncBought (not open market)—

Companies traded

  • TRAX First Tracks Biotherapeutics, Inc: other filings, last Jun 15, 2026
  • ANAB Anaptysbio, Inc: 2 sales, last Jan 6, 2026
  • PTLA Portola Pharmaceuticals Inc: other filings, last Jul 2, 2020
  • SNNA Sienna Biopharmaceuticals, Inc: 1 buy, last May 30, 2019
  • PFNX Pfenex Inc: other filings, last May 5, 2017
  • XNPT Xenoport Inc: 5 buys, last Jul 5, 2016
  • KYTH Kythera Biopharmaceuticals Inc: other filings, last Oct 1, 2015
  • HSP Hospira Inc: other filings, last Sep 3, 2015
  • DNDN Dendreon Corp: other filings, last Jan 3, 2014
  • GENZ Genzyme Corp: other filings, last Apr 4, 2011

Get free alerts when Dennis M Fenton files a new trade →